Search Results
May 28, 2026, 10:00 ET DENSO, Carnegie Mellon University to Present Leading AV Research at IEEE's CVPR 2026
models are trained and validated to how they operate efficiently in real-world environments," said Toru Hirano, vice president of North America R&D at DENSO. "The research we are sharing at CVPR reflects our commitment to developing innovative, practical technologies that help enable safer
More news about: DENSO
May 28, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Babcock & Wilcox Enterprises, Inc. and Certain Officers - BW
Group Holdings, Inc. ("BRC"), formerly B. Riley Financial, Inc. BRC's Co-Chief Operating Officer ("CEO") and Chairman of its Board of Directors is Bryant R. Riley ("Riley"). On November 4, 2025, B&W announced its entry into an agreement for a limited notice to proceed—that is, a preliminary agreement
More news about: Pomerantz LLP
May 28, 2026, 09:55 ET CVPR 2026 Fields 16,000+ Paper Submissions on Technical Advances in AI
types of attacks is capable of targeting any popular conditional generator model and achieving high precision."R2Seg: Training-Free OOD Medical Tumor Segmentation via Anatomical Reasoning and Statistical Rejection, Authors from Carnegie Mellon University,
More news about: Computer Vision Foundation (CVF)
May 28, 2026, 09:29 ET Haier Biomedical Achieves Double No. 1 Ranking in Euromonitor's Global Life Science Lab Equipment Report, Caps Three-Phase Global Expansion
focuses on embedding full operational capabilities in key regions: local warehousing, sales, marketing, product planning, and R&D.The company now operates overseas R&D centers in the UK, Italy, and Japan, each focused on specific product lines including centrifuges, cold chain and automation
More news about: Haier Biomedical
May 28, 2026, 09:07 ET Hyundai's New Hispanic Marketing Campaign for the 2026 Kona Gives "No Inventes" a Whole New Meaning
Lopez Negrete assembled a creative team spanning film, fashion, music, production, and post-production. The campaign was directed by filmmaker Phillip R. Lopez, whose visually grounded storytelling style helped bring the emotional nuance and spontaneity of the "No Inventes" concept to life.In the
More news about: Hyundai Motor America
May 28, 2026, 09:05 ET Gold Above $4,500 And A Permitted Tanzanian Project Heading For First Pour: How A Sub-$0.20 Junior Is Positioned For The Next Phase
process management has characterized as a positive procedural step. Harmony's FY26 capital allocation now includes R6.7 billion for the combined CSA and Eva copper projects, alongside R7.5 billion in sustaining capex across South African operations and Hidden Valley.Perpetua Resources Corp.
More news about: Equity Insider
May 28, 2026, 09:02 ET Weihai Medison Launches VEMERIX, Anchoring Its Minimally Invasive Surgery Platform on a Korea Joint Research Institute
disinfectant range and aesthetic injection devices.Underpinning the platform is the Medison Korea Joint Research Institute, a multidisciplinary R&D arm collaborating with senior PhD researchers from Seoul National University, Yonsei University, PNS Precision Research Institute and MFC Research
More news about: WEIHAI MEDISON (VEMERIX brand)
May 28, 2026, 09:02 ET Acer Expands Gaming Portfolio With Predator Atlas 8 Handheld Powered by Intel
A B X Y buttons, D-Pad, L/R full-size analog joysticks (Carbon Film), XBOX Game Bar Widget button, PredatorSense button, L/R bumpers, View button, Menu button, Power button with fingerprint sensor, Volume button(+/-), L2/R2 Hall-effect analog triggers, L/R Macro buttons, L/R Adjustable Trigger switches
More news about: Acer
May 28, 2026, 09:00 ET New Benchling Automation Closes the Loop Between Lab Instruments and AI
which is what it takes for the loop to scale past a single team."Benchling Automation is the latest in a series of launches building AI into R&D. That starts with infrastructure:
More news about: Benchling
May 28, 2026, 09:00 ET STLA Investor Alert: Stellantis N.V. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After CFO Allegedly Misrepresented Earnings Trajectory: SueWallSt
Executive Accountability: Douglas R. Ostermann Named in Securities ActionNEW YORK, May 28, 2026 /PRNewswire/ -- SueWallSt notifies investors that Douglas R. Ostermann, former Chief Financial Officer of Stellantis
More news about: SueWallSt.com
May 28, 2026, 09:00 ET SueWallSt Reminds Regencell Bioscience Holdings Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of June 23, 2026 - RGC
Alert: Claims Focus on Alleged Misrepresentations About Regencell's $1 Million R&D Budget Versus $14 Billion Market ValuationNEW YORK, May 28, 2026
More news about: SueWallSt.com
May 28, 2026, 09:00 ET Haier Biomedical Achieves Double No. 1 Ranking in Euromonitor's Global Life Science Lab Equipment Report, Caps Three-Phase Global Expansion
focuses on embedding full operational capabilities in key regions: local warehousing, sales, marketing, product planning, and R&D.The company now operates overseas R&D centers in the UK, Italy, and Japan, each focused on specific product lines including centrifuges, cold chain and automation
More news about: Haier Biomedical
May 28, 2026, 09:00 ET NOWDiagnostics Appoints Lisa Nibauer as Chief Executive Officer to Lead Next Phase of Innovation and Transformation
shareholders."Nibauer recently served as President of Diagnostics at OraSure Technologies, where she led a 500-person organization across Operations, R&D, Sales, and Marketing. During her tenure, she secured over $630 million in government contracts, achieved then-record annual revenue, successfully
More news about: NOWDiagnostics, Inc
May 28, 2026, 09:00 ET Hyundai Awarded Five Vehicles on the 2026 Best Adventure Vehicles List by U.S. News & World Report
headquarters in California, the Hyundai Motor Manufacturing Alabama assembly plant, the all-new Hyundai Motor Group Metaplant America, several cutting-edge R&D facilities and more than 855 independent dealers. These operations are part of Hyundai Motor Group, which is
More news about: Hyundai Motor America
May 28, 2026, 09:00 ET ASCO Using Ryght AI's Advanced Platform to Accelerate Site Selection for Breast Cancer Clinical Trial
feasibility assessments and site activation."Patients with metastatic breast cancer cannot afford to wait for access to clinical trials," said Julie R. Gralow, MD, FACP, FASCO, Chief Medical Officer and Executive Vice President of ASCO. "This collaboration aims to activate the most suitable sites faster
More news about: Ryght
May 28, 2026, 09:00 ET Nestlé and IdB Holding S.p.A. Enter Into Licensing Agreement for VOWST® in Europe
U.S. [email protected]. Rodrigues R, Barber GE, Ananthakrishnan AN. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection. Infect Control Hosp Epidemiol.
More news about: Nestlé Health Science U.S.
May 28, 2026, 09:00 ET Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to Treat Primary Biliary Cholangitis (PBC) Granted Priority Review by the US FDA
manufactures, and markets a broad range of healthcare therapies. The group employs over 29,000 people worldwide, including 1,500 scientists engaged in R&D, and is driven by its mission to unlock new possibilities in lifesciences through quality healthcare solutions that impact lives. The group aspires
More news about: Zydus Therapeutics, Inc.
May 28, 2026, 08:54 ET Florida Cancer Specialists & Research Institute Advances the Future of Cancer Care
Manish R. Patel, MD. "Through our ongoing clinical research efforts, we are generating new scientific insights that are advancing precision oncology for patients
More news about: Florida Cancer Specialists & Research Institute
May 28, 2026, 08:52 ET Findell Issues Report and Letter to CEO and Board of Directors of Figma
time. Estimates call for R&D to exceed 30% of revenues in 2026 (exclusive of stock-based compensation).1 We believe this number should be meaningfully reduced as product focus narrows. Figma should rely on a mix of internal R&D and tuck-in outsourced R&D by way of acqui-hires. Analyst
More news about: Findell Capital Management, LLC
May 28, 2026, 08:42 ET Bold Therapeutics' Clinical-Stage Anticancer Agent BOLD-100 Demonstrates Neuroprotective Potential when Utilized in Combination with FOLFOX for the Treatment of Advanced Gastrointestinal Cancers
cancers.Authors: Grainne M. O'Kane, Elena Elimova, Jennifer L. Spratlin, Rachel A. Goodwin, Elaine McWhirter, Petr Kavan, Joel R. Hecht, Dae Won Kim, Do-Youn Oh, Sun Young Rha, Seung Tae Kim, Moon Ki Choi, Dong-Hoe Koo, Mark Bazett, Malcolm Snow, Michelle A. Jones, Jim PankovichAbstract
More news about: Bold Therapeutics Inc.
May 28, 2026, 08:41 ET "Beyond the Shield": HONOR2U Research Reveals Critical Link Between Gear Performance and First Responder Mental Health
to treating them as vital "mental armor" for those who protect our communities. By directly involving frontline professionals and veterans in the R&D process, H2U addresses ergonomics and thermoregulation as non-negotiable health requirements.To truly honor those who serve this Memorial Day,
More news about: Honor2U
May 28, 2026, 08:30 ET Causaly Introduces Scientific Workflows to Turn Expert Scientific Methods into Repeatable, AI-Executed Processes in Life Sciences
consistently across their programs. We're giving R&D teams a way to scale their best methods and consistently support key pipeline decisions with highly relevant, actionable research, in line with rigorous scientific and organizational standards."R&D organizations rely on a mix of standard operating
More news about: Causaly
May 28, 2026, 08:30 ET Hongli Group Inc. Engages Battery Technology Expert Dr. Phillip A. Medina IV as Independent Technical Advisor for Energy Storage Initiatives
(NMR).After his time at IBM, Dr. Medina worked as the Chief Battery Scientist for an advanced battery technology developer, where he managed international R&D partnerships. He ran projects focused on fast-charging systems, solid-state battery structures, and high-energy-density technologies for electric mobility
More news about: Hongli Group Inc.
May 28, 2026, 08:18 ET EQT and Google Accelerate AI Adoption for Global Businesses
https://news.cision.com/eqt/r/eqt-and-google-accelerate-ai-adoption-for-global-businesses,c4354601The following files are available for download:
More news about: EQT
May 28, 2026, 08:16 ET EQT and Google Accelerate AI Adoption for Global Businesses
https://news.cision.com/eqt/r/eqt-and-google-accelerate-ai-adoption-for-global-businesses,c4354601The following files are available for download:
More news about: EQT